AstraZeneca Dec '11 sales at Rs 153.48 crore
Published on Fri, Feb 03, 2012 at 14:17 | Source : Moneycontrol.com
1872 Investors following AstraZeneca. Share this News with them.
 0
Like this story, share it with millions of investors on M3
AstraZeneca Dec '11 sales at Rs 153.48 crore
AstraZeneca Pharma has reported a sales turnover of Rs 153.48 crore and a net profit of Rs 14.94 crore for the quarter ended Dec '11
AstraZeneca Pharma has reported a sales turnover of Rs 153.48 crore and a net profit of Rs 14.94 crore for the quarter ended Dec '11.
| For the quarter ended Dec 2010 the sales turnover was Rs 132.52 crore and net profit was Rs 28.32 crore.
|
| | | Quarterly Results of AstraZeneca Pharma | -------- in Rs. Cr. -------- |
| | Dec '10 | | | Jun '11 | Dec '11 | | Sales Turnover | 132.52 | | | 137.48 | 153.48 | | Other Income | 1.53 | | | 1.50 | 1.50 | | Total Income | 134.06 | | | 138.99 | 154.99 | | Total Expenses | 89.41 | | | 112.37 | 131.10 | | Operating Profit | 43.11 | | | 25.11 | 22.38 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 44.64 | | | 26.61 | 23.88 | | Interest | -- | | | -- | -- | | PBDT | 44.64 | | | 26.62 | 23.89 | | Depreciation | 1.85 | | | 1.73 | 1.89 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 42.79 | | | 24.89 | 22.00 | | Tax | 14.47 | | | 8.14 | 7.06 | | Net Profit | 28.32 | | | 16.75 | 14.94 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 11.33 | | | 6.70 | 5.97 | | Book Value | -- | | | -- | -- | | Equity | 5.00 | | | 5.00 | 5.00 | | Reserves | -- | | | -- | -- | | Face Value | 2.00 | | | 2.00 | 2.00 | | Source : Dion Global Solutions Limited |
|
Trending News
Business News
|
Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)
The latest earning numbers FIRST on CNBC-TV18
Subscribe to
Moneycontrol Newsletters
|
